Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil combined with intensive aphasia rehabilitation and anodal transcranial direct current stimulation in chronic post-stroke aphasia
2017-002858-36Phase 3Active
- Sponsor
- Fundación IMABIS
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of donepezil in aphasia, sponsored by Fundación IMABIS. Primary endpoint: Severity of aphasia. Started Aug 2018; status: active.
02
Drugs
donepezil
03
Conditions
aphasia
Beyond the preview
Go deeper on 2017-002858-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002858-36.